Duchenne's Muscular Dystrophy (DMD) Enrolling by Invitation Phase 3 Trials for Ataluren (DB05016)

Also known as: Duchenne's Muscular Dystrophy / Duchenne Muscular Dystrophy (DMD) / Duchenne Muscular Dystrophy / Muscular Dystrophy, Duchenne / Muscular dystrophy

IndicationStatusPhase
DBCOND0066749 (Duchenne's Muscular Dystrophy (DMD))Enrolling by Invitation3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01247207Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD)Treatment